Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Israelow

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Nature|June 19, 2024
First encounter with SARS-CoV-2: immune portraits of COVID susceptibilityBenjamin Israelow, Akiko Iwasaki
Hepatology (Baltimore, Md.)|May 17, 2014
HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infectionBenjamin Israelow, Christopher M Narbus, Marion Sourisseau, et al.
Nature Biotechnology|December 6, 2024
Challenges for developing broad-based mucosal vaccines for respiratory virusesJunghwa Seo, Jordan Polster, Benjamin Israelow, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2Benjamin Israelow, Tianyang Mao, Jonathan Klein, et al.
Science Immunology|October 8, 2021
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2Benjamin Israelow, Tianyang Mao, Jonathan Klein, et al.
Nature Immunology|May 13, 2025
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in miceDong-Il Kwon, Tianyang Mao, Benjamin Israelow, et al.
Journal of Virology|September 17, 2010
Species-specific regions of occludin required by hepatitis C virus for cell entryMaria L Michta, Sharon E Hopcraft, Christopher M Narbus, et al.
Journal of Virology|September 16, 2011
HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycleChristopher M Narbus, Benjamin Israelow, Marion Sourisseau, et al.
Plos Pathogens|April 5, 2013
Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodiesMarion Sourisseau, Maria L Michta, Chati Zony, et al.
Nature Methods|July 4, 2012
High-throughput assessment of microRNA activity and function using microRNA sensor and decoy librariesGavriel Mullokandov, Alessia Baccarini, Albert Ruzo, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Nature|June 19, 2024
First encounter with SARS-CoV-2: immune portraits of COVID susceptibilityBenjamin Israelow, Akiko Iwasaki
Hepatology (Baltimore, Md.)|May 17, 2014
HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infectionBenjamin Israelow, Christopher M Narbus, Marion Sourisseau, et al.
Nature Biotechnology|December 6, 2024
Challenges for developing broad-based mucosal vaccines for respiratory virusesJunghwa Seo, Jordan Polster, Benjamin Israelow, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2Benjamin Israelow, Tianyang Mao, Jonathan Klein, et al.
Science Immunology|October 8, 2021
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2Benjamin Israelow, Tianyang Mao, Jonathan Klein, et al.
Nature Immunology|May 13, 2025
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in miceDong-Il Kwon, Tianyang Mao, Benjamin Israelow, et al.
Journal of Virology|September 17, 2010
Species-specific regions of occludin required by hepatitis C virus for cell entryMaria L Michta, Sharon E Hopcraft, Christopher M Narbus, et al.
Journal of Virology|September 16, 2011
HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycleChristopher M Narbus, Benjamin Israelow, Marion Sourisseau, et al.
Plos Pathogens|April 5, 2013
Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodiesMarion Sourisseau, Maria L Michta, Chati Zony, et al.
Nature Methods|July 4, 2012
High-throughput assessment of microRNA activity and function using microRNA sensor and decoy librariesGavriel Mullokandov, Alessia Baccarini, Albert Ruzo, et al.
Pageof 5